Target intelligence / Profile preview

Mediator of DNA damage checkpoint protein 1 (MDC1)

Target
MDC1
Molecular classification
Scaffold/adaptor protein, DNA damage response protein, Nuclear protein, Histone modification reader (binds phosphorylated histone H2AX), Other
01

Overview

Mediator of DNA damage checkpoint protein 1 (MDC1) is a large nuclear scaffold/adaptor protein essential for cellular responses to DNA double-strand breaks. It contains an N-terminal forkhead-associated (FHA) domain, two BRCA1 C-terminal (BRCT) motifs, and a central tandem repeat region. MDC1 directly binds phosphorylated histone H2AX (γH2AX) at sites of DNA damage, assembling and retaining DNA damage response (DDR) and repair proteins, and is critical for activation of the intra-S phase and G2/M cell cycle checkpoints. It coordinates downstream recruitment and activation of kinases like ATM, CHEK1, and CHEK2 and helps stabilize and regulate p53 activity. Loss or dysfunction of MDC1 causes radiosensitivity, impaired DNA damage checkpoints, defects in homologous recombination, and tumor susceptibility[2][4][6]. There are no current therapies directly targeting MDC1, but its role in DNA repair makes it a potential biomarker and research target for cancer and other genomic instability disorders.

Other names
Nuclear factor with BRCT domains 1 (NFBD1)KIAA0170Em:AB023051.5
02

Mechanism of action

Not applicable; no direct drugs currently approved. Mechanistically, targeting MDC1 would likely modulate DNA repair and checkpoint response pathways.

03

Biological functions

Cell cycle checkpoint activation (Intra-S phase and G2/M phase)DNA damage responseRecruitment of DNA repair factorsRegulation of apoptosisMaintenance of genomic stabilityHomologous recombinationCell survival determination
04

Disease associations

Cancer (increased susceptibility with loss of function)Infertility (especially male infertility in knockout mice)RadiosensitivityGlioma susceptibilityNijmegen breakage syndromeOther genomic instability syndromes
05

Safety considerations

Potential for increased genomic instabilityincreased cancer riskimpaired DNA repairand fertility risks if MDC1 is inhibited or lost[2][4][6]
06

Biomarkers

MDC1 protein levels and function may serve as biomarkers for DNA repair capacitygenomic instabilityradiosensitivityand possibly cancer susceptibility, but not currently standardized for patient selection[6]

Beyond the preview

Go deeper on Mediator of DNA damage checkpoint protein 1 (MDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator of DNA damage checkpoint protein 1 (MDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call